Development and Validation of GC-MS and HPLC Methods for the Determination of Simvastatin in Tablets and Human Urine

References

• Stein, A.E., Plotkin, D., Bays, H. et al. (2000). Effects of Simvastatin (40 and 80 mg/day) in Patients with Mixed Hyperlipidemia. Am. J. Cardiol. 86: 406–411. doi: 10.1016/S0002-9149(00)00955-3
   PubMed Web of Science ®Google Scholar
• Davignon, J. (2004). Beneficial cardiovascular pleiotropic effects of statins. Circulation. 109: 39–43.
   Web of Science ®Google Scholar
• McKay, A A., Bernard, P.L., Iain, B.M., Neil, C.T. and Foo, Y.L. (2004). Novel Anti-Inflammatory Role of Simvastatin in a Murine Model of Allergic Asthma. The Journal of Immunology. 172: 2903–2908
   PubMed Web of Science ®Google Scholar
• Sassano, A. and Platanias, L.C. (2008). Statins in tumor suppression. Cancer Letters. 260(1-2): p. 11–9. doi: 10.1016/j.canlet.2007.11.036
   PubMed Web of Science ®Google Scholar
• Arayne, M.S., Sultana, N., Hussain, F. et al. (2007). Validated spectrophotometric method for quantitative determination of simvastatin in pharmaceutical formulations and human serum. J. Anal. Chem. 62: 536–541. doi: 10.1134/S106193480706007X
   Web of Science ®Google Scholar
• Moussa, B.A., Mohamed, M.F., Youssef, N.F. (2010). Derivative spectrophotometric method for simultaneous determination of ezetimibe and simvastatin in combined tablets. Eur. J. Chem. 1: 348–351. doi: 10.5155/eurjchem.1.4.348-351.110
   Google Scholar
• Malenovic, A., Ivanovic, D., Medenica, M., Jancic, B., Markovic, S. (2004). Retention modelling in liquid chromatographic separation of simvastatin and six impurities using a microemulsion as eluent. J. Sep. Sci. 27: 1087–1092. doi: 10.1002/jssc.200401748
   PubMed Web of Science ®Google Scholar
• Hefnawy, M., Al-Omar, M., Julkhuf, S. (2009). Rapid and sensitive simultaneous determination of ezetimibe and simvastatin from their combination drug products by monolithic silica high-performance liquid chromatographic column. J. Pharm. Biomed. Anal. 50: 527–534. doi: 10.1016/j.jpba.2009.05.002
   PubMed Web of Science ®Google Scholar
• Silva, T.X., Oliveira, M.A., Oliveira, R.B. et al. (2012). Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin. J. Chromatogr. Sci. J. 50: 831–838.
   PubMed Web of Science ®Google Scholar
• Partani, P., Verma, S.M., Monif, T. (2016). Development and validation of an LC-MS-MS method for determination of simvastatin and simvastatin acid in human plasma: Application to a pharmacokinetic study. J. Chromatogr. Sci. 54: 1385–1396. doi: 10.1093/chromsci/bmw087
   PubMedGoogle Scholar
• Venkateswara, B., Vidyadhara, S., Prasad, S. and Asheer, D. (2016). A novel analytical method development and validation for the estimation of simvastatin in bulk and pharmaceutical dosage forms by RP-HPLC. Der. Pharmacia. Lettre. 8: 230–236.
   Google Scholar
• Alhazmi, H., Alnami, A., Arishi, M., Alameer, R., Al Bratty, M., Rehman, Z., Javed, S. and Arbab, I. (2017). A fast and validated reversed-phase HPLC method for simultaneous determination of simvastatin, atorvastatin, telmisartan and irbesartan in bulk drugs and tablet formulations. Sci. Pharm. 86: 1. doi: 10.3390/scipharm86010001
   PubMed Web of Science ®Google Scholar
• Tajabadi, F., Ghambarian, M., Yamini, Y. (2015). Evaluation of three-phase hollow fiber micro-extraction based on two immiscible solvents coupled to GC and HPLC for determination of statin drugs in biological fluids. Anal. Methods. 7: 2959–2967. doi: 10.1039/C4AY02980A
   Web of Science ®Google Scholar
• 14. Dixit, R.P., Barhate, C.R., Padhye, S.G. et al. (2008). Stability indicating HPTLC method for simultaneous determination of ezetimibe and simvastatin. Chromatographia. 67:101-107.
   Google Scholar
• Lakshmana, R.A., Suneetha, D. (2010). High Performance thin layer chromatographic estimation of simvastatin in bulk and tablet dosage form. Asian J. Chem. 22: 27–30.
   Google Scholar
• Takano, T., Hata, S.A. (1990). A selected ion monitoring method for quantifying simvastatin and its acid form in human plasma, using the ferroceneboronate derivative. Biomed. Environ. Mass Spectrom. 19: 577–81. doi: 10.1002/bms.1200190910
   PubMedGoogle Scholar
• Morris, M.J., Gilbert, J.D., Hsieh, J.Y. et al. (1993). Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/ chemical ionization mass spectrometry. Biol. Mass Spectrom. 22: 1–8. doi: 10.1002/bms.1200220102
   PubMedGoogle Scholar
• Procópio, J.V.V., De Souza, V.G., Da Costa, R.A., Correia, L.P., De Souza, F.S., MacÊdo, R.O. (2011). Application of thermal analysis and pyrolysis coupled to GC/MS in the qualification of simvastatin pharmaceutical raw material. J. Therm. Anal. Calorim. 106: 665–670.
   Google Scholar
• Sirén, H., Kaijanen, L., Kaartinen, S., Väre, M., Riikonen, P., Jernström, E. (2014). Determination of statins by gas chromatography - EI/MRM - tandem mass spectrometry: Fermentation of pine samples with pleurotus ostreatus. J. Pharm. Biomed. Anal. 94: 196–202.
   Google Scholar
• Srinivasu, M.K., Raju, A.N., Reddy, G.O. (2002). Determination of lovastatin and simvastatin in pharmaceutical dosage forms by MEKC. J. Pharm. Biomed. Anal. 29: 715–721. doi: 10.1016/S0731-7085(02)00128-0
   PubMed Web of Science ®Google Scholar
• Damic, M., Nigovic, B. (2010). Fast analysis of statins in pharmaceuticals by MEKC. Chromatographia. 71: 233–240. doi: 10.1365/s10337-009-1432-1
   Web of Science ®Google Scholar
• Yardimci, C., Ozaltin, N. (2010). Simultaneous Determination of Ezetimibe and Simvastatin in Pharmaceutical Preparations by MEKC. J. Chromatogr. Sci. 48: 95–99. doi: 10.1093/chromsci/48.2.95
   PubMed Web of Science ®Google Scholar
• Coruh, Ö. and Özkan, S.A. (2006). Determination of the antihyperlipidemic simvastatin by various voltammetric techniques in tablets and serum samples. Die Pharmazie. 61: 285–290.
   PubMed Web of Science ®Google Scholar
• Sharaf El-Din, M., Attia, K., Nassar, M., Kaddah, M. (2010). Colorimetric determination of simvastatin and lovastatin in pure form and in pharmaceutical formulations, Spectrochimica Acta. 76A: 423–428. doi: 10.1016/j.saa.2010.04.015
   PubMedGoogle Scholar
• Maggon, K. (2005). The statin war. Express Pharma Pulse, 21 April.
   Google Scholar
• Cheng, H., Schwartz, M.S., Vickers, S. et al. (1994). Metabolic disposition of simvastatin in patients with t-tube drainage. Drug Metab. Dispos. 22 :139–42.
   Google Scholar
• Liu, L., Zhang, R., Zhao, J.J., et al. (2003). Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection. J. Pharm. Biomed. Anal. 32: 107–23.
   Google Scholar
• Yang, H.J., Choi, M.J., Wen, H. et al. (2011). An effective assessment of simvastatin-induced toxicity with NMR-based metabonomics approach, PLoS One 6 : e16641.
   Google Scholar
• Ballantyne, C.M., Corsini, A., Davidson, M.H. et al. (2003). Risk for myopathy with statin therapy in high-risk patients. Arch Intern. Med. 163: 553–564. doi: 10.1001/archinte.163.5.553
   PubMed Web of Science ®Google Scholar
• Belal, T., Awad, T., Clark, C.R. (2009). Stability-indicating simultaneous determination of paracetamol and three of its related substances using a direct GC/MS method. Journal of AOAC International. 92: 1622–1630.
   PubMed Web of Science ®Google Scholar
• Belal, T., Awad, T., Clark, C.R. (2009). Determination of paracetamol and tramadol hydrochloride in pharmaceutical mixture using HPLC and GC-MS. J. Chromatogr. Sci. 47: 849–854. doi: 10.1093/chromsci/47.10.849
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization (ICH). (2005). Technical Requirements for the Registration of Pharmaceutical for Human Use, Validation of Analytical Procedures; Text and Methodology Q2 (R1), Geneva, 1.
   Google Scholar
• The United States Pharmacopoeia 30th edition, the National Formulary 25th edition, US Pharmacopeial Convention: Rockville, MD, 2007; Electronic version.
   Google Scholar
• Miller, J.C. & Miller, J.N. Statistics and Chemometrics for Analytical Chemistry, 5t h edn. Pearson Education Limited: Harlow, England. 2005; 39-73, 107-149, 256.
   Google Scholar
• Duggan, D.E., Vickers, S. (1990). Physiological disposition of HMG-CoA-reductase inhibitors, Drug Metb. Rev. 22: 333–362. doi: 10.3109/03602539009041088
   PubMed Web of Science ®Google Scholar